GlaxoSmithKline boss Emma Walmsley ‘needs ten years in job’


One of Emma Walmsley’s former lieutenants calls for GlaxoSmithKline chief to be given more time as she comes under pressure from hedge fund

One of Emma Walmsley’s former lieutenants has called for the GlaxoSmithKline chief to be given more time as she comes under pressure from a US hedge fund. 

Amir Reichman – a GSK director under Walmsley for four years – said: ‘I admire her skills in managing the direction of the company and improving its innovation and culture’. 

Under pressure: Emma Walmsley has faced scrutiny since it emerged Elliott Management had taken a multibillion-pound stake in GSK in April

In charge since 2017, she has faced scrutiny since it emerged Elliott Management had taken a multibillion-pound stake in GSK in April. 

The hedge fund is yet to make its intentions public, but The Mail on Sunday has revealed it has had talks with major investors and asked whether she is the right person to lead the firm. 

Reichman, chief executive of Israeli firm BiondVax Pharmaceuticals, was head of GSK’s global vaccines engineering core technologies until earlier this year.

He said: ‘She needs up to ten years. It is too big a behemoth to change the direction easily. She needs at least a few more years to see her work through.’   



Source link

Spread the love

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

What do you think?

Regional airline Stobart Air collapses after rescue talks fall through

Vertu Motors faces revolt over chief executive’s pay